Spots Global Cancer Trial Database for extrahepatic bile duct cancer
Every month we try and update this database with for extrahepatic bile duct cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder | NCT00084942 | Extrahepatic Bi... Gallbladder Can... | capecitabine gemcitabine hyd... | 18 Years - | Roswell Park Cancer Institute | |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
| Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer | NCT00903396 | Anal Cancer Carcinoma of th... Colorectal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Gastrointestina... Liver Cancer Nausea and Vomi... Pancreatic Canc... Primary Periton... Small Intestine... | palonosetron hy... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
| DX-8951f in Treating Patients With Biliary Cancer | NCT00005938 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | exatecan mesyla... | 16 Years - | Daiichi Sankyo | |
| Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer | NCT00003411 | Extrahepatic Bi... Gallbladder Can... Pancreatic Canc... | motexafin gadol... radiation thera... | 18 Years - 120 Years | University of Pittsburgh | |
| Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer | NCT00073905 | Extrahepatic Bi... Gallbladder Can... Liver Cancer Pain | capecitabine pl... | 18 Years - 80 Years | Swiss Group for Clinical Cancer Research | |
| Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer | NCT00003427 | Anal Cancer Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Gastrointestina... Liver Cancer Pancreatic Canc... Small Intestine... | irinotecan hydr... oxaliplatin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer | NCT00009893 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | fluorouracil gemcitabine hyd... leucovorin calc... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | NCT00004895 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine... | octreotide acet... | 18 Years - | Northwestern University | |
| S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma | NCT00033540 | Extrahepatic Bi... Gallbladder Can... | capecitabine gemcitabine hyd... | 18 Years - | SWOG Cancer Research Network | |
| S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma | NCT00033540 | Extrahepatic Bi... Gallbladder Can... | capecitabine gemcitabine hyd... | 18 Years - | SWOG Cancer Research Network | |
| S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct | NCT00789958 | Extrahepatic Bi... Gallbladder Can... | capecitabine gemcitabine hyd... 3-dimensional c... intensity-modul... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer | NCT00266097 | Extrahepatic Bi... Gallbladder Can... Pancreatic Canc... | erlotinib hydro... gemcitabine hyd... oxaliplatin radiation thera... gemcitabine hyd... Oxaliplatin | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | NCT00544193 | Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | gemcitabine hyd... polymerase chai... immunohistochem... conventional su... intraoperative ... radiation thera... | 18 Years - 70 Years | City of Hope Medical Center | |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
| Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer | NCT00363584 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | capecitabine clinical observ... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer | NCT00266097 | Extrahepatic Bi... Gallbladder Can... Pancreatic Canc... | erlotinib hydro... gemcitabine hyd... oxaliplatin radiation thera... gemcitabine hyd... Oxaliplatin | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer | NCT01111591 | Bile Duct Cance... Pancreatic Canc... | Cox2 inhibitor ... | 19 Years - 70 Years | Seoul National University Hospital | |
| Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer | NCT00559598 | Extrahepatic Bi... Pancreatic Canc... | proteomic profi... medical chart r... | - | National Institutes of Health Clinical Center (CC) | |
| Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer | NCT00486356 | Extrahepatic Bi... Gallbladder Can... Gastric Cancer Liver Cancer Unspecified Adu... | capecitabine carboplatin epirubicin hydr... microarray anal... polymorphism an... pharmacological... | 18 Years - 120 Years | University of Nebraska | |
| Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery | NCT00513539 | Extrahepatic Bi... Gallbladder Can... | porfimer sodium biliary stentin... | 18 Years - | University College, London | |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
| Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer | NCT00009893 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | fluorouracil gemcitabine hyd... leucovorin calc... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract Diseases | NCT05896956 | Biliary Tract D... Gallbladder Can... Extrahepatic Bi... Intrahepatic Ch... Biliary Tract N... Gall Stone | no intervention... | 18 Years - 74 Years | RenJi Hospital | |
| Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer | NCT00363584 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | capecitabine clinical observ... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers | NCT00832637 | Hepatocellular ... Cholangiocellul... Cholangiocarcin... Bile Duct Cance... Periampullary A... Gallbladder Can... Extrahepatic Bi... | Cisplatin Erlotinib Gemcitabine | 18 Years - | New Mexico Cancer Care Alliance | |
| Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer | NCT00073905 | Extrahepatic Bi... Gallbladder Can... Liver Cancer Pain | capecitabine pl... | 18 Years - 80 Years | Swiss Group for Clinical Cancer Research | |
| Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer | NCT00019474 | Extrahepatic Bi... Gastric Cancer Gastrointestina... Liver Cancer Pancreatic Canc... Small Intestine... | filgrastim recombinant int... fluorouracil hydroxyurea | 18 Years - 120 Years | Montefiore Medical Center | |
| Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer | NCT00003296 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | filgrastim pegylated lipos... | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer | NCT00658593 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | capecitabine gemcitabine hyd... quality-of-life... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer | NCT00658593 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | capecitabine gemcitabine hyd... quality-of-life... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer | NCT00003557 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | dolastatin 10 | 18 Years - | University of Chicago | |
| Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers | NCT02349412 | Liver Cancer Anxiety Disorde... Depression Small Cell Lung... Extrahepatic Bi... Malignant Mesot... Pancreatic Canc... Esophageal Canc... Gastric Cancer Non-small Cell ... | Early palliativ... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer | NCT00059865 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | gemcitabine hyd... pemetrexed diso... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors | NCT00262769 | Extrahepatic Bi... Gallbladder Can... | cisplatin gemcitabine hyd... | 16 Years - | University College, London | |
| Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | NCT00004895 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine... | octreotide acet... | 18 Years - | Northwestern University | |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
| Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery | NCT01313377 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | gemcitabine hyd... oxaliplatin clinical observ... adjuvant therap... quality-of-life... | 18 Years - 120 Years | UNICANCER | |
| DX-8951f in Treating Patients With Biliary Cancer | NCT00005938 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | exatecan mesyla... | 16 Years - | Daiichi Sankyo | |
| Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer | NCT00836992 | Anal Cancer Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Head and Neck C... Liver Cancer Lung Cancer Pancreatic Canc... Small Intestine... | 18 Years - 120 Years | Mayo Clinic | ||
| S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma | NCT00033540 | Extrahepatic Bi... Gallbladder Can... | capecitabine gemcitabine hyd... | 18 Years - | SWOG Cancer Research Network | |
| Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer | NCT02293954 | Breast Cancer Colon Cancer Extrahepatic Bi... Gallbladder Can... Gastrointestina... Liver and Intra... Lung Cancer Metastatic Canc... Pancreatic Canc... Rectal Cancer Thyroid Gland M... Unspecified Adu... | radionuclide im... positron emissi... laboratory biom... pharmacological... Cu 64 anti-CEA ... | 18 Years - | City of Hope Medical Center | |
| Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer | NCT00987766 | Extrahepatic Bi... Gallbladder Can... Liver Cancer Pancreatic Canc... Periampullary A... Small Intestine... | erlotinib hydro... gemcitabine hyd... oxaliplatin laboratory biom... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| DX-8951f in Treating Patients With Biliary Cancer | NCT00005938 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | exatecan mesyla... | 16 Years - | Daiichi Sankyo | |
| S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct | NCT00789958 | Extrahepatic Bi... Gallbladder Can... | capecitabine gemcitabine hyd... 3-dimensional c... intensity-modul... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy | NCT00919061 | Extrahepatic Bi... Gallbladder Can... | Gemcitabine Cisplatin Sorafenib | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct | NCT00010088 | Extrahepatic Bi... Pancreatic Canc... | fluorouracil gemcitabine hyd... leucovorin calc... conventional su... radiation thera... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer | NCT00003296 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | filgrastim pegylated lipos... | 18 Years - | National Cancer Institute (NCI) | |
| Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor | NCT00021047 | Esophageal Canc... Extrahepatic Bi... Gastric Cancer Head and Neck C... Liver Cancer Unspecified Adu... | capecitabine carboplatin epirubicin hydr... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas | NCT00003923 | Extrahepatic Bi... Gallbladder Can... Liver Cancer Pancreatic Canc... | porfimer sodium | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | NCT00544193 | Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | gemcitabine hyd... polymerase chai... immunohistochem... conventional su... intraoperative ... radiation thera... | 18 Years - 70 Years | City of Hope Medical Center | |
| Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery | NCT01313377 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | gemcitabine hyd... oxaliplatin clinical observ... adjuvant therap... quality-of-life... | 18 Years - 120 Years | UNICANCER | |
| Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer | NCT00030511 | Extrahepatic Bi... Liver Cancer | fluorouracil conventional su... radiation thera... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction | NCT00004910 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Gastrointestina... Pancreatic Canc... Quality of Life Small Intestine... | bowel obstructi... quality-of-life... | 18 Years - | Northwestern University | |
| Biological Therapy in Treating Patients With Metastatic Cancer | NCT00004604 | Breast Cancer Colorectal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Head and Neck C... Liver Cancer Lung Cancer Metastatic Canc... Ovarian Cancer Pancreatic Canc... Testicular Germ... | CEA RNA-pulsed ... | 18 Years - | Duke University | |
| Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer | NCT00005997 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | becatecarin | 18 Years - | Case Comprehensive Cancer Center | |
| Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy | NCT00919061 | Extrahepatic Bi... Gallbladder Can... | Gemcitabine Cisplatin Sorafenib | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer | NCT00387348 | Colorectal Canc... Depression Esophageal Canc... Extrahepatic Bi... Fatigue Gallbladder Can... Gastric Cancer Liver Cancer Lung Cancer Pancreatic Canc... | escitalopram ox... Placebo | 35 Years - 85 Years | Massachusetts General Hospital | |
| Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer | NCT00559598 | Extrahepatic Bi... Pancreatic Canc... | proteomic profi... medical chart r... | - | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
